Researchers developing molecular delivery vehicles for genetic therapies

November 13, 2006

Researchers at New York University are working to develop molecular delivery vehicles that can be used to transport nucleic acids into diverse cell types, which may lead to eventual applications in genetic therapies. Their work is described as part of the cover story in the Nov. 13 issue of the American Chemical Society publication Chemical and Engineering News.

Scientists have been exploring RNA interference (RNAi) as a gene therapy technique to silence genes that are improperly produced. The "RNAi" approach requires the delivery into the cell of short pieces of the genetic material Ribonucleic Acid (RNA). These synthetic short RNA "oligos" can then pair with specific sites in the cell's own RNA, targeting the genetic messages for destruction and turning off expression of the corresponding genes. However, the widespread clinical use of this genetic therapy relies upon technical improvements, including new delivery vehicles such as the one Kent Kirshenbaum, an assistant professor in NYU's Department of Chemistry, and colleagues present in their work.

The NYU researchers use a modular linear molecule to deliver therapeutic RNA into cells. The molecule has a positively charged site that forms favorable stabilizing interactions with the negatively charged RNA, and a fatty component that interacts with cell membranes. The molecules and RNA form complexes, which protect the RNA from being degraded and deliver it to cells. As a result, the targeted deleterious genes are silenced.

Their research concentrates on making the transition from the lab into real-life smoother. Their linear molecule can be used to deliver small therapeutic RNAs into cell types that are much more representative of cellular targets that investigators are likely to encounter in clinical situations.

Kirshenbaum and his coworkers are now focused on understanding the physical chemical characteristics that give enhanced activity to their molecule, and then use the knowledge to generate a set of more sophisticated delivery reagents for siRNA.

"Our goal is to develop a platform that would allow us to create a library that could be used in different settings or for delivery to different cell types," he told Chemical and Engineering News.

Source: New York University

Explore further: Continuous-flow, electrically-triggered, single cell-level electroporation

Related Stories

Don't kill the messenger RNA

February 15, 2017

FedEx, UPS, DHL—when it comes to sending packages, choices abound. But the most important delivery service you may not have heard of? mRNA. That's short for messenger RNA, which is how your DNA sends blueprints to the protein-assembly ...

Overcoming hurdles in CRISPR gene editing to improve treatment

February 7, 2017

More and more scientists are using the powerful new gene-editing tool known as CRISPR/Cas9, a technology isolated from bacteria, that holds promise for new treatment of such genetic diseases as cystic fibrosis, muscular dystrophy ...

Recommended for you

Controlling ice formation

March 24, 2017

(Phys.org)—Researchers have demonstrated that ice crystals will grow along straight lines in a controlled way on microgrooved surfaces. Compared to the random formation of ice crystals on smooth surfaces, the ice on the ...

OSIRIS-REx asteroid search tests instruments, science team

March 24, 2017

During an almost two-week search, NASA's OSIRIS-REx mission team activated the spacecraft's MapCam imager and scanned part of the surrounding space for elusive Earth-Trojan asteroids—objects that scientists believe may ...

Astronomers identify purest, most massive brown dwarf

March 24, 2017

An international team of astronomers has identified a record breaking brown dwarf (a star too small for nuclear fusion) with the 'purest' composition and the highest mass yet known. The object, known as SDSS J0104+1535, is ...

Study into who is least afraid of death

March 24, 2017

A new study examines all robust, available data on how fearful we are of what happens once we shuffle off this mortal coil. They find that atheists are among those least afraid of dying... and, perhaps not surprisingly, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.